Emerging economies have failed to raise their share of funding for tuberculosis R&D, contributing to a global shortfall, according to a report by the Treatment Action Group.
Global tuberculosis research funding fell by US$53.4 million last year—the biggest drop since TAG started to track global TB funding 11 years ago.
At the same time, the global TB epidemic is proving worse than previously thought. The disease killed 1.8 million people last year, making it the deadliest infectious disease in the world.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.